Hypermarcas (OTCMKTS:HYPMY) Short Interest Update
by Michael Walen · The Markets DailyHypermarcas (OTCMKTS:HYPMY – Get Free Report) was the recipient of a significant drop in short interest during the month of September. As of September 15th, there was short interest totaling 2,343 shares, a drop of 62.4% from the August 31st total of 6,225 shares. Based on an average trading volume of 12,182 shares, the days-to-cover ratio is currently 0.2 days. Approximately 0.0% of the company’s shares are short sold.
Hypermarcas Trading Up 2.0%
Shares of HYPMY stock traded up $0.09 on Tuesday, reaching $4.49. The company had a trading volume of 2,100 shares, compared to its average volume of 19,542. The stock has a market cap of $3.16 billion, a PE ratio of 8.98 and a beta of 0.71. The company has a 50-day moving average of $4.29 and a 200-day moving average of $4.32. The company has a current ratio of 1.86, a quick ratio of 1.26 and a debt-to-equity ratio of 0.50. Hypermarcas has a 12 month low of $3.71 and a 12 month high of $5.50.
Hypermarcas (OTCMKTS:HYPMY – Get Free Report) last issued its quarterly earnings data on Thursday, August 6th. The company reported $0.14 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $0.13 by $0.01. Hypermarcas had a net margin of 19.77% and a return on equity of 12.68%. On average, equities analysts forecast that Hypermarcas will post 0.53 earnings per share for the current year.
Wall Street Analyst Weigh In
Separately, Jefferies Financial Group upgraded shares of Hypermarcas to a “strong-buy” rating in a research report on Monday, July 20th. One analyst has rated the stock with a Strong Buy rating and one has assigned a Hold rating to the company’s stock. Based on data from MarketBeat, Hypermarcas presently has an average rating of “Buy”.
Read Our Latest Report on HYPMY
Hypermarcas Company Profile
Hypermarcas SA was a Brazilian consumer health and pharmaceutical company that developed, manufactured and marketed branded products for healthcare, personal care and consumer markets. Its portfolio historically included over-the-counter medicines, prescription products, vitamins, toiletries, cosmetics and other household or personal-care brands.
The company expanded through acquisitions and operated primarily in Brazil, building a broad portfolio of locally recognized brands. In the mid-2010s, Hypermarcas began divesting its non-pharmaceutical businesses to concentrate on healthcare and medicines.